Developer docs
API playgroundTry for free, no card

Search company profiles

Kinexus Corporation

Full company profile

uuid0035ed1

Namestring
Kinexus Corporation
Legal namestring
Kinexus Bioinformatics Corporation
Websiteurl
kinexus.ca
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Kinexus Bioinformatics Corporation, founded in 1999 in Vancouver, British Columbia, is a private, founder-led proteomics services company specializing in cell signaling protein profiling for biomedical researchers. The company operates an integrated discovery platform anchored by antibody microarray technology (the Kinex KAM-2025 array carrying 2,027 antibodies across 949 unique signaling proteins), custom macroarrays (peptide, antibody, lysate), in silico kinase substrate prediction algorithms (IKSP, IKMP, IPMP), in vitro kinase/phosphatase substrate profiling (SPIMA), kinase inhibitor specificity screening (KIDMAS), multi-immunoblotting validation services (Kinetworks KCPS 1.0 and KCSS 1.0), mass spectrometry protein identification (PIMS), custom peptide synthesis (CSPP, CPAP SPOT arrays), and custom rabbit polyclonal antibody production (CAP). Underlying the platform are proprietary bioinformatics algorithms co-developed with the University of British Columbia and Simon Fraser University, and a large in-house catalog of more than 1,600 validated antibodies and 1,600+ stock synthetic peptides.

Kinexus generates revenue through three primary streams: (1) fee-for-service proteomics and bioinformatics work delivered through a mail-in/courier model in which clients send cell or tissue lysates to the Vancouver facility with a typical 3-4 week turnaround; (2) standalone product sales of antibodies (typically US$99 per 25 µg) and peptides via a Shopify e-commerce storefront; and (3) unit-priced in silico bioinformatics reports (IKSP at US$399 per kinase, IKMP at US$99 per analysis, IPMP on quote) and ancillary services such as custom graphics (US$99 per slide) and KiNetscape custom pathway mapping (from US$400). Customers are distributed globally across academic research institutions and biopharmaceutical companies in over 40 countries, with over 3,500 lifetime clients served and more than 10,000 cumulative proteomics screens performed over the company's 26-year operating history.

The company maintains and distributes open-access cell-signaling reference data through its SigNET KnowledgeBank — covering PhosphoNET (950,000+ phosphorylation sites), KinaseNET (530+ kinases), KiNECTOR (22,000+ kinase-substrate relationships), DrugKiNET (800+ compounds, 105,000+ experiments), and KiNET-AM (1.5 million+ measurements from nearly 2,000 microarray analyses) — which functions simultaneously as an educational funnel, a thought-leadership asset, and a competitive differentiator. Kinexus has remained privately held and founder-operated throughout its history, with no disclosed institutional funding, M&A activity, or recapitalization events.

Short descriptiontext

Kinexus Corporation is a private Vancouver-based proteomics services company founded in 1999 that provides antibody microarray, immunoblotting, in silico kinase prediction, and custom antibody/peptide services to academic and biopharmaceutical researchers in over 40 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
proteomics services, antibody microarrays, kinase profiling, phosphoproteomics research, custom peptide synthesis
Industry3 codes
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Proteomics Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Proteomics Services
TypeProfessional Services
Description

Core revenue from providing antibody microarray services (KAM-2025), immunoblotting services (Kinetworks™ KCPS 1.0 and KCSS 1.0), kinase/phosphatase substrate profiling (SPIMA), kinase inhibitor profiling (KIDMAS), mass spectrometry protein identification (PIMS), custom peptide and antibody production, and custom graphics services. Turnaround time is typically 3-4 weeks.

kinexus.ca
2Standalone Products (Antibodies and Peptides)
TypeOne Time License
Description

Sale of over 1,600 validated rabbit polyclonal antibodies and over 1,600 stock synthetic peptides as standalone products through their Shopify e-commerce platform. Antibodies typically priced at US$99 per 25 µg.

kinexus.ca
3In Silico Bioinformatics Services
TypeSubscription Recurring
Description

IKSP (In Silico Kinase Substrate Specificity Prediction) at US$399 per kinase, IKMP (In Silico Kinase Match Prediction) at US$99 per analysis, and IPMP (In Silico Phosphoprotein Match Prediction) services for phosphosite and kinase prediction.

kinexus.ca
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details8 tiers
1Custom Antibody Production (CAP)
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

US$1,299 package price inclusive of antigen peptide synthesis, rabbit immunizations and peptide affinity purification. Typical median yield of 1.5 mg affinity-purified antibody (range 0.1 mg to over 10 mg). Alternative price of US$1,199 mentioned on homepage.

kinexus.ca
2IKSP In Silico Kinase Substrate Specificity Prediction Service
ModelUnit PricingBilling cadencePay-as-you-go
Notes

US$399 per kinase analysis. Client provides Uniprot or NCBI accession number of protein kinase.

kinexus.ca
3IKMP In Silico Kinase Match Prediction Service
ModelUnit PricingBilling cadencePay-as-you-go
Notes

US$99 per analysis. Client provides 15 amino acid sequence surrounding the phosphosite.

kinexus.ca
4IPMP In Silico Phosphoprotein Match Prediction Service
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Custom in silico service for any of 21,000 human proteins providing predicted phosphosites and kinase targeting scores for approximately 500 kinases. Contact for pricing.

kinexus.ca
5Custom Graphics Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

US$99 per slide or figure. Available in Adobe Illustrator, Photoshop (eps, tiff, jpeg, png) or Adobe PDF format.

kinexus.ca
6Standalone Antibodies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Typically US$99 per 25 µg. Over 1,600 antibodies available including pan-specific and phosphosite-specific.

kinexus.ca
7Custom Kinase-Substrate Profiling (SPIMA) Service
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Less than US$3,000 for panel of physiological substrates, phosphosites, and detecting phosphosite antibodies identified for a supplied experimental model system and kinase.

kinexus.ca
8KiNetscape Custom Pathway Mapping
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Publication-ready custom KiNetscape maps available for as little as US$400 each.

kinexus.ca
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 9 records shown
1Kinex™
Description

Antibody microarray platform including KAM-2025 product line

kinexus.ca
+8 more records
Core offering1 text field

Kinexus Corporation provides integrated proteomics services and products for biomedical researchers, centered on its proprietary Kinex™ KAM-2025 antibody microarray platform that profiles cell signaling proteins across 949 unique targets. The company delivers custom antibody and peptide synthesis, multi-immunoblotting validation (Kinetworks™), kinase/phosphatase substrate profiling (SPIMA, KIDMAS), in silico kinase substrate prediction, mass spectrometry protein identification, and maintains open-access SigNET knowledgebases covering millions of phosphorylation sites and kinase relationships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 3,500 clients served in over 40 countries since 1999
+3 more records
Product overview1 text field

Kinexus offers an integrated proteomics and bioinformatics services platform centered on antibody microarray technology (Kinex™ KAM-2025) and kinase/phosphatase research. The platform comprises: (1) high-content antibody microarrays and custom macroarrays (peptide, antibody, lysate); (2) in silico kinase substrate prediction services (IKSP, IKMP, IPMP) and in vitro kinase/phosphatase substrate profiling (SPIMA); (3) custom synthesis services for peptides (CSPP, CPAP SPOT arrays) and antibodies (CAP); (4) immunoblotting validation services (Kinetworks™ KCPS, KCSS); (5) mass spectrometry protein identification (PIMS); and (6) open-access knowledgebases (PhosphoNET, KinaseNET, KiNECTOR, DrugKiNET, KiNET-AM) containing millions of data points on human phosphorylation sites, protein kinases, kinase-substrate relationships, and kinase-drug interactions. These services are designed to work together as a unified discovery pipeline from initial biomarker screening through validation.

Product and service17 records
1Kinex™ KAM-2025 Antibody Microarray
CategoryProteomics Service
Description

High-content antibody microarray featuring 2,027 pan- and phosphosite-specific antibodies for tracking approximately 949 unique signaling proteins including protein kinases, phosphatases, and other cell signaling proteins particularly important in oncology, neurology, and diabetes research.

2Kinetworks™ KCPS 1.0 Multi-Antibody Western Blotting
CategoryValidation Service
Description

Multi-antibody immunoblotting service evaluating up to 18 different antibodies against proteins in a single tissue or cell lysate sample for validation of microarray results.

3Kinetworks™ KCSS 1.0 Multi-Sample Western Blotting
CategoryValidation Service
Description

Multi-sample immunoblotting service tracking a protein target across up to 14 different cell or tissue specimens on a single Western blot for dose responses, time courses, or biological reproducibility.

4CAP Custom Antibody Production
CategoryCustom Reagent Service
Description

Custom production of affinity-purified rabbit polyclonal antibodies against signaling proteins including peptide synthesis, rabbit immunizations, and peptide affinity purification, starting at US$1,299.

5CSPP Custom Synthetic Peptide Production
CategoryCustom Reagent Service
Description

Synthesis of high-quality soluble peptides including phosphopeptides, cyclic peptides, and custom-labeled peptides (FITC, biotin, etc.) for kinase substrates, pseudo-substrate inhibitors, and immunogenic peptides.

6CPAP Custom SPOT Peptide Arrays
CategoryCustom Reagent Service
Description

Peptide synthesis directly on cellulose membranes using SPOT technology for high-density arrays, supporting epitope mapping, substitution analysis, truncation analysis, and random/combinatorial/phosphopeptide library screening.

7SPIMA Kinase/Phosphatase Substrate Profiling
CategoryProteomics Service
Description

In vitro service using KAM-2025 antibody microarray to identify physiological substrates for over 360 recombinant human protein kinases and 40 protein phosphatases in cell and tissue lysates.

8KIDMAS Kinase-Inhibitor Profiling
CategoryProteomics Service
Description

Kinase Inhibitor Displacement Microarray-based Screen service that determines specificity of kinase inhibitors by detecting competitive binding at active sites using FSBA probe technology across at least 364 captured human protein kinases.

9IKSP In Silico Kinase Substrate Specificity Prediction
CategoryBioinformatics Service
Description

Bioinformatics service using proprietary algorithms to predict specificity of nearly 500 human protein kinases based on catalytic domain sequences and known substrate phosphosite pairs, priced at US$399 per kinase.

10IKMP In Silico Kinase Substrate Match Prediction
CategoryBioinformatics Service
Description

Bioinformatics service to identify optimal kinases for a given phosphorylation site sequence, testing any known or putative phosphosite against scoring matrices for nearly 500 human protein kinases, priced at US$99 per analysis.

11IPMP In Silico Phosphoprotein Match Prediction
CategoryBioinformatics Service
Description

Comprehensive bioinformatics service identifying putative phosphosites in human proteins and predicting kinases likely to phosphorylate these sites across approximately 500 kinases, with evolutionary conservation analysis.

12KCPM Custom Peptide Macroarray
CategoryCustom Array Service
Description

Custom peptide macroarrays with robotically spotted peptides on cellulose or nitrocellulose membranes or glass slides for epitope mapping, kinase and phosphatase substrate specificity, and protein-protein interaction studies.

13KCAM Custom Antibody Macroarray
CategoryCustom Array Service
Description

Custom antibody macroarrays with robotically spotted antibodies on membranes or glass slides for detection of proteins in bodily fluids and tissue lysates.

14KRLM Custom Lysate Macroarray
CategoryCustom Array Service
Description

Custom arrays of robotically spotted tissue and cell lysates or biofluid specimens for biomarker validation across large sample cohorts.

15PIMS Protein Identification by Mass Spectrometry
CategoryMass Spectrometry Service
Description

Protein fingerprinting service using LC-MS/MS mass spectrometry to identify cross-immunoreactive proteins detected in Kinetworks or SPIMA analyses.

16Custom Graphics Services
CategoryGraphics Service
Description

Production of publication and presentation-ready figures including colored slides, bar graphs, and signaling pathway diagrams from Kinetworks and Kinex microarray results, at US$99 per slide.

17Kinexus Validated Antibodies and Peptides Catalog
CategoryReagent Product
Description

Online catalog of over 1,600 in-house developed pan- and phosphosite-specific antibodies and over 1,600 stock synthetic peptides sold as standalone reagents via Shopify, typically priced at US$99 per 25 µg of antibody.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1University of British Columbia (UBC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership with UBC's Departments of Mathematics and Computer Science and the MITACS Group for development of proprietary kinase substrate prediction algorithms using mutual information and amino acid interaction scoring. Collaboration resulted in 'cracking the kinase code' to predict kinase specificity from catalytic domain amino acid sequences.

kinexus.ca
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership for development of proprietary kinase substrate prediction algorithms. Collaboration with UBC and SFU mathematics and computer science departments created algorithms for predicting specificity of nearly 500 human protein kinases.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Abcam is a major antibody reagent supplier (now part of Danaher) with a catalog covering thousands of targets including phosphorylation-specific antibodies. Overlaps with Kinexus on validated rabbit polyclonal antibodies and recombinant antibody reagents for cell signaling research.

TypeDirect peer
Description

RayBiotech is a direct competitor in antibody microarray and multiplex immunoassay services for biomarker discovery, with overlapping technology (antibody arrays) and customer base (academic and translational researchers).

TypeDirect peer
Description

CST is the dominant commercial supplier of phospho-specific and signaling antibodies, offering antibody-based proteomics tools and validation services. Direct overlap with Kinexus in antibody reagents for cell signaling and kinase research, particularly for academic and pharma discovery customers.

TypeEmerging player
Description

Olink's Proximity Extension Assay (PEA) technology is an emerging next-generation proteomics platform competing for the same biomarker discovery budgets that fund Kinexus antibody microarrays, particularly in pharma translational research.

TypeEmerging player
Description

Active Motif provides antibodies, kits, and services for epigenetics, chromatin, and cell signaling research. Comparable as a specialty proteomics tools provider with overlapping antibody catalog and service offerings for translational researchers.

TypeBroad incumbent
Description

Promega is a broad life science tools incumbent offering antibodies, peptides, mass spectrometry reagents, and custom protein production services that overlap with several Kinexus service lines (CAP, CSPP, PIMS).

TypeBroad incumbent
Description

Bio-Techne is a diversified life science tools incumbent offering antibodies, proteins, ELISA kits, and proteomics platforms (including Simple Western). Comparable as a broad-spectrum protein research tools provider serving similar academic and pharma customers.

TypeDirect peer
Description

PhosphoSolutions is a small specialty vendor focused exclusively on phospho-specific antibodies for neuroscience and signaling research. Direct niche competitor with similar technology foundation and customer profile.

TypeBroad incumbent
Description

Standard BioTools acquired SomaLogic and operates the SOMAscan aptamer-based proteomics platform, a high-multiplex competitor targeting similar biomarker discovery and translational proteomics applications as Kinexus.

TypeDirect peer
Description

Full Moon BioSystems produces antibody arrays and phosphorylation assays that directly overlap with Kinexus's KAM antibody microarray platform and target the same academic and biomarker discovery customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kinexus Corporation

Proteomics Research Serviceskinexus.ca

Kinexus Corporation is a private Vancouver-based proteomics services company founded in 1999 that provides antibody microarray, immunoblotting, in silico kinase prediction, and custom antibody/peptide services to academic and biopharmaceutical researchers in over 40 countries.

What Kinexus Corporation does

Kinexus Bioinformatics Corporation, founded in 1999 in Vancouver, British Columbia, is a private, founder-led proteomics services company specializing in cell signaling protein profiling for biomedical researchers. The company operates an integrated discovery platform anchored by antibody microarray technology (the Kinex KAM-2025 array carrying 2,027 antibodies across 949 unique signaling proteins), custom macroarrays (peptide, antibody, lysate), in silico kinase substrate prediction algorithms (IKSP, IKMP, IPMP), in vitro kinase/phosphatase substrate profiling (SPIMA), kinase inhibitor specificity screening (KIDMAS), multi-immunoblotting validation services (Kinetworks KCPS 1.0 and KCSS 1.0), mass spectrometry protein identification (PIMS), custom peptide synthesis (CSPP, CPAP SPOT arrays), and custom rabbit polyclonal antibody production (CAP). Underlying the platform are proprietary bioinformatics algorithms co-developed with the University of British Columbia and Simon Fraser University, and a large in-house catalog of more than 1,600 validated antibodies and 1,600+ stock synthetic peptides.

Kinexus generates revenue through three primary streams: (1) fee-for-service proteomics and bioinformatics work delivered through a mail-in/courier model in which clients send cell or tissue lysates to the Vancouver facility with a typical 3-4 week turnaround; (2) standalone product sales of antibodies (typically US$99 per 25 µg) and peptides via a Shopify e-commerce storefront; and (3) unit-priced in silico bioinformatics reports (IKSP at US$399 per kinase, IKMP at US$99 per analysis, IPMP on quote) and ancillary services such as custom graphics (US$99 per slide) and KiNetscape custom pathway mapping (from US$400). Customers are distributed globally across academic research institutions and biopharmaceutical companies in over 40 countries, with over 3,500 lifetime clients served and more than 10,000 cumulative proteomics screens performed over the company's 26-year operating history.

The company maintains and distributes open-access cell-signaling reference data through its SigNET KnowledgeBank — covering PhosphoNET (950,000+ phosphorylation sites), KinaseNET (530+ kinases), KiNECTOR (22,000+ kinase-substrate relationships), DrugKiNET (800+ compounds, 105,000+ experiments), and KiNET-AM (1.5 million+ measurements from nearly 2,000 microarray analyses) — which functions simultaneously as an educational funnel, a thought-leadership asset, and a competitive differentiator. Kinexus has remained privately held and founder-operated throughout its history, with no disclosed institutional funding, M&A activity, or recapitalization events.

Kinexus Corporation firmographics

Firmographics
Name
Kinexus Corporation
Legal name
Kinexus Bioinformatics Corporation
Website
https://kinexus.ca
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Kinexus Corporation is a private Vancouver-based proteomics services company founded in 1999 that provides antibody microarray, immunoblotting, in silico kinase prediction, and custom antibody/peptide services to academic and biopharmaceutical researchers in over 40 countries.
Ownership category
akta.pro rank

Kinexus Corporation industry classification

Industry
Product category
Proteomics Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Proteomics services
  • Antibody microarrays
  • Kinase profiling
  • Phosphoproteomics research
  • Custom peptide synthesis

Where Kinexus Corporation is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Kinexus Corporation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Proteomics Services: Core revenue from providing antibody microarray services (KAM-2025), immunoblotting services (Kinetworks™ KCPS 1.0 and KCSS 1.0), kinase/phosphatase substrate profiling (SPIMA), kinase inhibitor profiling (KIDMAS), mass spectrometry protein identification (PIMS), custom peptide and antibody production, and custom graphics services. Turnaround time is typically 3-4 weeks.
  2. Standalone Products (Antibodies and Peptides): Sale of over 1,600 validated rabbit polyclonal antibodies and over 1,600 stock synthetic peptides as standalone products through their Shopify e-commerce platform. Antibodies typically priced at US$99 per 25 µg.
  3. In Silico Bioinformatics Services: IKSP (In Silico Kinase Substrate Specificity Prediction) at US$399 per kinase, IKMP (In Silico Kinase Match Prediction) at US$99 per analysis, and IPMP (In Silico Phosphoprotein Match Prediction) services for phosphosite and kinase prediction.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCustom Antibody Production (CAP)
Unit PricingPay-as-you-goIKSP In Silico Kinase Substrate Specificity Prediction Service
Unit PricingPay-as-you-goIKMP In Silico Kinase Match Prediction Service
Unit PricingPay-as-you-goIPMP In Silico Phosphoprotein Match Prediction Service
Unit PricingPay-as-you-goCustom Graphics Services
Unit PricingPay-as-you-goStandalone Antibodies
Unit PricingPay-as-you-goCustom Kinase-Substrate Profiling (SPIMA) Service
Unit PricingPay-as-you-goKiNetscape Custom Pathway Mapping

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Kinexus Corporation product offering

Product offering

Core offering

Kinexus Corporation provides integrated proteomics services and products for biomedical researchers, centered on its proprietary Kinex™ KAM-2025 antibody microarray platform that profiles cell signaling proteins across 949 unique targets. The company delivers custom antibody and peptide synthesis, multi-immunoblotting validation (Kinetworks™), kinase/phosphatase substrate profiling (SPIMA, KIDMAS), in silico kinase substrate prediction, mass spectrometry protein identification, and maintains open-access SigNET knowledgebases covering millions of phosphorylation sites and kinase relationships.

Product overview

Kinexus offers an integrated proteomics and bioinformatics services platform centered on antibody microarray technology (Kinex™ KAM-2025) and kinase/phosphatase research. The platform comprises: (1) high-content antibody microarrays and custom macroarrays (peptide, antibody, lysate); (2) in silico kinase substrate prediction services (IKSP, IKMP, IPMP) and in vitro kinase/phosphatase substrate profiling (SPIMA); (3) custom synthesis services for peptides (CSPP, CPAP SPOT arrays) and antibodies (CAP); (4) immunoblotting validation services (Kinetworks™ KCPS, KCSS); (5) mass spectrometry protein identification (PIMS); and (6) open-access knowledgebases (PhosphoNET, KinaseNET, KiNECTOR, DrugKiNET, KiNET-AM) containing millions of data points on human phosphorylation sites, protein kinases, kinase-substrate relationships, and kinase-drug interactions. These services are designed to work together as a unified discovery pipeline from initial biomarker screening through validation.

Differentiator

Problem solved

Functional benefit

Brands

  • Kinex™: Antibody microarray platform including KAM-2025 product line
  • Kinetworks™
  • SigNET KnowledgeBank
  • KiNET-AM
  • CSPP
  • CPAP
  • SPIMA
  • KIDMAS
  • PIMS

Products and services

  • Kinex™ KAM-2025 Antibody Microarray High-content antibody microarray featuring 2,027 pan- and phosphosite-specific antibodies for tracking approximately 949 unique signaling proteins including protein kinases, phosphatases, and other cell signaling proteins particularly important in oncology, neurology, and diabetes research.
  • Kinetworks™ KCPS 1.0 Multi-Antibody Western Blotting Multi-antibody immunoblotting service evaluating up to 18 different antibodies against proteins in a single tissue or cell lysate sample for validation of microarray results.
  • Kinetworks™ KCSS 1.0 Multi-Sample Western Blotting Multi-sample immunoblotting service tracking a protein target across up to 14 different cell or tissue specimens on a single Western blot for dose responses, time courses, or biological reproducibility.
  • CAP Custom Antibody Production Custom production of affinity-purified rabbit polyclonal antibodies against signaling proteins including peptide synthesis, rabbit immunizations, and peptide affinity purification, starting at US$1,299.
  • CSPP Custom Synthetic Peptide Production Synthesis of high-quality soluble peptides including phosphopeptides, cyclic peptides, and custom-labeled peptides (FITC, biotin, etc.) for kinase substrates, pseudo-substrate inhibitors, and immunogenic peptides.
  • CPAP Custom SPOT Peptide Arrays Peptide synthesis directly on cellulose membranes using SPOT technology for high-density arrays, supporting epitope mapping, substitution analysis, truncation analysis, and random/combinatorial/phosphopeptide library screening.
  • SPIMA Kinase/Phosphatase Substrate Profiling In vitro service using KAM-2025 antibody microarray to identify physiological substrates for over 360 recombinant human protein kinases and 40 protein phosphatases in cell and tissue lysates.
  • KIDMAS Kinase-Inhibitor Profiling Kinase Inhibitor Displacement Microarray-based Screen service that determines specificity of kinase inhibitors by detecting competitive binding at active sites using FSBA probe technology across at least 364 captured human protein kinases.
  • IKSP In Silico Kinase Substrate Specificity Prediction Bioinformatics service using proprietary algorithms to predict specificity of nearly 500 human protein kinases based on catalytic domain sequences and known substrate phosphosite pairs, priced at US$399 per kinase.
  • IKMP In Silico Kinase Substrate Match Prediction Bioinformatics service to identify optimal kinases for a given phosphorylation site sequence, testing any known or putative phosphosite against scoring matrices for nearly 500 human protein kinases, priced at US$99 per analysis.
  • IPMP In Silico Phosphoprotein Match Prediction Comprehensive bioinformatics service identifying putative phosphosites in human proteins and predicting kinases likely to phosphorylate these sites across approximately 500 kinases, with evolutionary conservation analysis.
  • KCPM Custom Peptide Macroarray Custom peptide macroarrays with robotically spotted peptides on cellulose or nitrocellulose membranes or glass slides for epitope mapping, kinase and phosphatase substrate specificity, and protein-protein interaction studies.
  • KCAM Custom Antibody Macroarray Custom antibody macroarrays with robotically spotted antibodies on membranes or glass slides for detection of proteins in bodily fluids and tissue lysates.
  • KRLM Custom Lysate Macroarray Custom arrays of robotically spotted tissue and cell lysates or biofluid specimens for biomarker validation across large sample cohorts.
  • PIMS Protein Identification by Mass Spectrometry Protein fingerprinting service using LC-MS/MS mass spectrometry to identify cross-immunoreactive proteins detected in Kinetworks or SPIMA analyses.
  • Custom Graphics Services Production of publication and presentation-ready figures including colored slides, bar graphs, and signaling pathway diagrams from Kinetworks and Kinex microarray results, at US$99 per slide.
  • Kinexus Validated Antibodies and Peptides Catalog Online catalog of over 1,600 in-house developed pan- and phosphosite-specific antibodies and over 1,600 stock synthetic peptides sold as standalone reagents via Shopify, typically priced at US$99 per 25 µg of antibody.

Quantifiable outcome

  • Over 3,500 clients served in over 40 countries since 1999
  • +3 more outcomes

Companies that use Kinexus Corporation

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Kinexus Corporation technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Kinexus Corporation partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • University of British Columbia (UBC)coreStrategic or Co-development PartnerAcademic partnership with UBC's Departments of Mathematics and Computer Science and the MITACS Group for development of proprietary kinase substrate prediction algorithms using mutual information and amino acid interaction scoring. Collaboration resulted in 'cracking the kinase code' to predict kinase specificity from catalytic domain amino acid sequences.
  • Simon Fraser University (SFU)coreStrategic or Co-development PartnerAcademic partnership for development of proprietary kinase substrate prediction algorithms. Collaboration with UBC and SFU mathematics and computer science departments created algorithms for predicting specificity of nearly 500 human protein kinases.

Scale indicators15 records

Recent moves6 records

Expansion highlights4 records

Kinexus Corporation competitors and assessment

Company assessment

Direct peers

  • Abcam: Abcam is a major antibody reagent supplier (now part of Danaher) with a catalog covering thousands of targets including phosphorylation-specific antibodies. Overlaps with Kinexus on validated rabbit polyclonal antibodies and recombinant antibody reagents for cell signaling research.
  • RayBiotech: RayBiotech is a direct competitor in antibody microarray and multiplex immunoassay services for biomarker discovery, with overlapping technology (antibody arrays) and customer base (academic and translational researchers).
  • Cell Signaling Technology (CST): CST is the dominant commercial supplier of phospho-specific and signaling antibodies, offering antibody-based proteomics tools and validation services. Direct overlap with Kinexus in antibody reagents for cell signaling and kinase research, particularly for academic and pharma discovery customers.
  • PhosphoSolutions: PhosphoSolutions is a small specialty vendor focused exclusively on phospho-specific antibodies for neuroscience and signaling research. Direct niche competitor with similar technology foundation and customer profile.
  • Full Moon BioSystems: Full Moon BioSystems produces antibody arrays and phosphorylation assays that directly overlap with Kinexus's KAM antibody microarray platform and target the same academic and biomarker discovery customers.

Emerging players

  • Olink Holding: Olink's Proximity Extension Assay (PEA) technology is an emerging next-generation proteomics platform competing for the same biomarker discovery budgets that fund Kinexus antibody microarrays, particularly in pharma translational research.
  • Active Motif: Active Motif provides antibodies, kits, and services for epigenetics, chromatin, and cell signaling research. Comparable as a specialty proteomics tools provider with overlapping antibody catalog and service offerings for translational researchers.

Broad incumbents

  • Promega Corporation: Promega is a broad life science tools incumbent offering antibodies, peptides, mass spectrometry reagents, and custom protein production services that overlap with several Kinexus service lines (CAP, CSPP, PIMS).
  • Bio-Techne: Bio-Techne is a diversified life science tools incumbent offering antibodies, proteins, ELISA kits, and proteomics platforms (including Simple Western). Comparable as a broad-spectrum protein research tools provider serving similar academic and pharma customers.
  • Standard BioTools (formerly Fluidigm / SomaLogic): Standard BioTools acquired SomaLogic and operates the SOMAscan aptamer-based proteomics platform, a high-multiplex competitor targeting similar biomarker discovery and translational proteomics applications as Kinexus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Kinexus Corporation social profiles

Digital presence

Kinexus Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kinexus Corporation leadership team

Management profile

Number of profiles

Profiles2 records

Kinexus Corporation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kinexus Corporation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kinexus Corporation

What does Kinexus Corporation do?

Kinexus Corporation provides integrated proteomics services and products for biomedical researchers, centered on its proprietary Kinex™ KAM-2025 antibody microarray platform that profiles cell signaling proteins across 949 unique targets. The company delivers custom antibody and peptide synthesis, multi-immunoblotting validation (Kinetworks™), kinase/phosphatase substrate profiling (SPIMA, KIDMAS), in silico kinase substrate prediction, mass spectrometry protein identification, and maintains open-access SigNET knowledgebases covering millions of phosphorylation sites and kinase relationships.

Is Kinexus Corporation a public or private company?

Kinexus Corporation is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Kinexus Corporation founded?

Kinexus Corporation was founded in 1999. It employs 11 to 50 people.

Where is Kinexus Corporation based?

Kinexus Corporation is headquartered in Vancouver, Canada, in the North America region.

How does Kinexus Corporation make money?

Three revenue lines are on record. Proteomics Services are the primary driver. The others are standalone Products (Antibodies and Peptides) and in Silico Bioinformatics Services.

Who are Kinexus Corporation's main competitors?

Direct peers on record are Abcam, RayBiotech, Cell Signaling Technology (CST), PhosphoSolutions and Full Moon BioSystems. Emerging players are Olink Holding and Active Motif. Broad incumbents are Promega Corporation, Bio-Techne and Standard BioTools (formerly Fluidigm / SomaLogic).

Does Kinexus Corporation have an API?

No public API is recorded for Kinexus Corporation.

What industry is Kinexus Corporation in?

Kinexus Corporation's product category is Proteomics Research Services. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals